Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  1998-02-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  PMID 9488587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemoprevention by inducers of carcinogen detoxication enzymes.

  1997cited by this paper
• Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.

  1997cited by this paper
• Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.

  1997cited by this paper
• SHORT COMMUNICATION: Inhibition of aflatoxin M1 excretion in rat urine during dietary intervention with oltipraz

  1996cited by this paper
• Principles of Chemoprevention

  1996cited by this paper
• Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

  1996cited by this paper
• Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.

  1996cited by this paper
• Chemoprevention of cancer.

  1996cited by this paper
• Variability of molecular biomarker measurements from nonlinear calibration curves.

  1996cited by this paper
• Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan

  1996cited by this paper
• Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect.

  1996cited by this paper
• Regulation of glutathione S-transferases and aldehyde reductase by chemoprotectors: studies of mechanisms responsible for inducible resistance to aflatoxin B1.

  1996cited by this paper
• Carcinogen‐DNA and protein adducts: Biomarkers for cohort selection and modifiable endpoints in chemoprevention trials

  1996cited by this paper
• Use of carcinogen-DNA and carcinogen-protein adduct biomarkers for cohort selection and as modifiable end points in chemoprevention trials.

  1996cited by this paper
• Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.

  1996cited by this paper
• Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.

  1995cited by this paper
• Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture.

  1995cited by this paper
• Primary prevention of hepatocellular carcinoma

  1995cited by this paper
• Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz.

  1995cited by this paper
• Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.

  1995cited by this paper
• Chemoprevention of cancer.

  1994cited by this paper
• Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism.

  1994cited by this paper
• A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.

  1994cited by this paper
• Molecular biomarkers for aflatoxins and their application to human cancer prevention.

  1994cited by this paper
• Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones.

  1994cited by this paper
• Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones.

  1993cited by this paper
• Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer.

  1993cited by this paper
• 13 – Strategies for Chemoprotection against Aflatoxin-Induced Liver Cancer

  1993cited by this paper
• Oltipraz: A laboratory and clinical review

  1993cited by this paper
• Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.

  1993cited by this paper
• Molecular biomarkers for human chemical carcinogen exposures.

  1993cited by this paper
• Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.

  1992cited by this paper
• Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa.

  1992cited by this paper
• Glutathione conjugation of aflatoxin B1 exo- and endo-epoxides by rat and human glutathione S-transferases.

  1992cited by this paper
• Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.

  1991cited by this paper
• Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.

  1990cited by this paper
• Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1.

  1988cited by this paper
• Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.

  1987cited by this paper
• Disposition of 14C-oltipraz in animals. Pharmacokinetics in mice, rats and monkeys. Comparison of the biotransformation in the infected mouse and in the schistosomes.

  1985cited by this paper
• Chemoprevention of cancer.

  1985cited by this paper
• Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography.

  1985cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper
• Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation.

  1982cited by this paper

• Fifty Years of Aflatoxin Research in Qidong, China: A Celebration of Team Science to Improve Public Health

  2025cites this paper
• Possible Mechanisms of the Interplay between Drugs and Mycotoxins—Is There a Possible Impact?

  2022cites this paper
• 5,5′-(Piperazine-1,4-diyl)bis(4-chloro-3H-1,2-dithiol-3-one)

  2022cites this paper
• Comparative Study of Binding Pockets in Human CYP1A2, CYP3A4, CYP3A5, and CYP3A7 with Aflatoxin B1, a Hepato-Carcinogen, by Molecular Dynamics Simulation & Principal Component Analysis.

  2022cites this paper
• Aflatoxin B1: metabolism, toxicology, and its involvement in oxidative stress and cancer development

  2021cites this paper
• Current Landscape of NRF2 Biomarkers in Clinical Trials

  2020cites this paper
• Retrospective and Prospective Look at Aflatoxin Research and Development from a Practical Standpoint

  2019cites this paper
• Aflatoxin B1 metabolism: Regulation by phase I and II metabolizing enzymes and chemoprotective agents.

  2018cites this paper
• Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action

  2018influential citation
• Caloric restriction - A promising anti-cancer approach: From molecular mechanisms to clinical trials.

  2017cites this paper
• Mycotoxin Control in Low- and Middle-income Countries

  2016cites this paper
• Roles of dietary aflatoxin exposure in the acquisition and progression of infectious diseases and an intervention study with ACCS100

  2016cites this paper
• Cancer Prevention Studies in High-Risk Areas of Traditional Chinese Cancers

  2015cites this paper
• Mycotoxin Control in Low- and Middle-

  2015cites this paper
• Cancer Prevention Research in China

  2015cites this paper
• Of Mice, Rats, and Men: Could Nrf2 Activation Protect against Aflatoxin Heptocarcinogenesis in Humans?

  2014cites this paper
• Mycotoxins in a changing global environment--a review.

  2014cites this paper
• Aflatoxin biomarkers in human biological samples and their potential reduction by probiotic lactobacillus casei Shirota strain

  2014cites this paper
• Aflatoxin B1 Chemoprevention Strategies in Countries with Frequent Exposure to Mycotoxins

  2014cites this paper
• Research Proposal : Mycotoxin Detection in Dried Blood

  2014cites this paper
• Role of the Keap1-Nrf2 pathway in cancer.

  2014cites this paper
• An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride

  2014cites this paper
• Exposure biornarkers in chemoprevention studies of liver

  2014cites this paper
• Development and Validation of Exposure Biomarkers to Dietary Contaminants Mycotoxins: A Case for Aflatoxin and Impaired Child Growth

  2013cites this paper
• The Molecular Epidemiology of Chronic Aflatoxin Driven Impaired Child Growth

  2013cites this paper
• The emerging role of the Nrf2–Keap1 signaling pathway in cancer

  2013cites this paper
• Human Exposure to Foodborne Toxins in Ghana: Intervention Strategy for Reduction of Aflatoxin and Fumonisin Bioavailability

  2013influential citation
• Aflatoxin B1 Up-Regulates Insulin Receptor Substrate 2 and Stimulates Hepatoma Cell Migration

  2012cites this paper
• Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).

  2012cites this paper
• Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review

  2012influential citation
• The role of biomarkers in evaluating human health concerns from fungal contaminants in food

  2012cites this paper
• Chemoprevention of hepatic cancer in aflatoxin endemic areas

  2012cites this paper
• In Vitro and In Vivo Inhibition of Human Bladder Cancer by Broccoli Isothiocyanates: Characterization, Absorption, Metabolism and Interconversion

  2011cites this paper
• The prevention of infection-associated cancers.

  2011cites this paper
• Liver cancer epidemic in China: past, present and future.

  2011cites this paper
• Aflatoxin B1 - Prevention of Its Genetic Damage by Means of Chemical Agents

  2011cites this paper
• Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology.

  2011cites this paper
• Targeting NRF2 signaling for cancer chemoprevention.

  2010cites this paper
• Involvement of pregnane X receptor in the regulation of CYP2B6 gene expression by oltipraz in human hepatocytes.

  2010cites this paper
• Biomarkers of Exposure, Effect, and Susceptibility

  2010cites this paper
• A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults

  2010cites this paper
• Is It Time to Advance the Chemoprevention of Environmental Carcinogenesis with Microdosing Trials?

  2009cites this paper
• Chemical genomics of cancer chemopreventive dithiolethiones

  2009cites this paper
• Inhibition of colon carcinogenesis by post-initiation induction of NQO1 in Sprague-Dawley rats.

  2009cites this paper
• Effects of Chlorophyll and Chlorophyllin on Low-Dose Aflatoxin B1 Pharmacokinetics in Human Volunteers

  2009cites this paper
• Deciphering hepatocellular carcinoma: from bench to bedside and back.

  2009cites this paper
• Environmental Carcinogens and Risk for Human Liver Cancer

  2009influential citation
• Therapeutic potential of dithiolethiones for hepatic diseases.

  2009cites this paper
• Environmental exposure measurement in cancer epidemiology.

  2008cites this paper
• Dibenzoylmethane activates Nrf2-dependent detoxification pathway and inhibits benzo(a)pyrene induced DNA adducts in lungs.

  2008cites this paper
• NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine

  2008cites this paper
• Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention.

  2008cites this paper
• Aflatoxin, Hepatitis B Virus and Liver Cancer: A Paradigm for Molecular Epidemiology

  2008cites this paper
• [The risk assessment of mycotoxins and its international trends].

  2008cites this paper
• Mixed inhibition of P450 3A4 as a chemoprotective mechanism against aflatoxin B1-induced cytotoxicity with cis-terpenones.

  2008cites this paper
• Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries.

  2008cites this paper
• Biomarkers of Aflatoxin Exposure and a Dietary Intervention

  2007cites this paper
• Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1--a multi-center and multi-biomarker study.

  2007cites this paper
• Interactions of the major metabolite of the cancer chemopreventive drug oltipraz with cytochrome c: a novel pathway for cancer chemoprevention.

  2007cites this paper
• Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity.

  2006cites this paper
• Nrf2-mediated Induction of Cytoprotective Enzymes by 15-Deoxy-Δ12,14-Prostaglandin J2 Is Attenuated by Alkenal/one Oxidoreductase*

  2006cites this paper
• Oltipraz chemoprevention trial in Qidong, People's Republic of China: unaltered oxidative biomarkers.

  2006cites this paper
• Quantitative analysis and chronic dosimetry of the aflatoxin B1 plasma albumin adduct Lys-AFB1 in rats by isotope dilution mass spectrometry.

  2006cites this paper
• Cancer chemopreventive oltipraz generates superoxide anion radical.

  2005cites this paper
• Nrf2 as a novel molecular target for chemoprevention.

  2005cites this paper
• The chemopreventive efficacy of inhaled oltipraz particulates in the B[a]P-induced A/J mouse lung adenoma model.

  2005cites this paper
• Aflatoxin and hepatitis B virus biomarkers: A paradigm for complex environmental exposures and cancer risk

  2005cites this paper
• Protection against aflatoxin-B1-induced liver mutagenesis by Scutellaria baicalensis.

  2005cites this paper
• Glutathione-mediated formation of oxygen free radicals by the major metabolite of oltipraz.

  2005cites this paper
• Role of metabolism and viruses in aflatoxin-induced liver cancer.

  2005cites this paper
• Clinical Strategies for Chemoprevention of Liver Cancer

  2005cites this paper
• The Diet, Prostate Inflammation, and the Development of Prostate Cancer

  2004cites this paper
• Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas.

  2004cites this paper
• Inducers of Enzymes That Protect Against Carcinogens and Oxidants

  2004cites this paper
• Prostate cancer prevention.

  2004cites this paper
• GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer

  2004cites this paper
• Oltipraz, 3H-1,2-dithiole-3-thione, and sulforaphane induce overlapping and protective antioxidant responses in murine microglial cells.

  2004cites this paper
• Oltipraz inhibits inducible nitric oxide synthase in vitro and inhibits nitric oxide production in activated microglial cells.

  2004cites this paper
• Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo

  2004cites this paper
• NF-κB Activation by the Chemopreventive Dithiolethione Oltipraz Is Exerted through Stimulation of MEKK3 Signaling*

  2004cites this paper
• A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway.

  2004cites this paper
• Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment

  2004cites this paper
• Biological Relevance of Adduct Detection to the Chemoprevention of Cancer

  2004cites this paper
• Dietary Aflatoxin Exposure and Chemoprevention of Cancer: A Clinical Review

  2003cites this paper
• Translational strategies for cancer prevention in liver

  2003cites this paper
• Molecular epidemiology in cancer prevention

  2003cites this paper
• Modulation of hepatic drug metabolizing enzymes and oxidative status by rooibos (Aspalathus linearis) and Honeybush (Cyclopia intermedia), green and black (Camellia sinensis) teas in rats.

  2003cites this paper
• Phase 2 enzyme induction by the major metabolite of oltipraz.

  2003cites this paper
• Inhibition of aflatoxin B1 mutagenicity by cyclopiazonic acid in the presence of human liver preparations.

  2003cites this paper
• Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.

  2003cites this paper
• Mechanisms in Carcinogenesis and Cancer Prevention

  2003cites this paper
• Hepatitis B virus and hepatocellular carcinoma.

  2003cites this paper
• Inadequate "caretaker" gene function and human cancer development.

  2003cites this paper
• Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin.

  2003cites this paper
• Complementary DNA cloning, protein expression, and characterization of alpha-class GSTs from Macaca fascicularis liver.

  2002cites this paper
• Enhancing Effects of Oltipraz on the Development of Spontaneous Hepatic Lesions in LEC Rats

  2002cites this paper
• Aflatoxin, hepatitis and worldwide liver cancer risks.

  2002cites this paper
• Strategies for chemoprevention of liver cancer.

  2002cites this paper
• The toxicology of aflatoxins as a basis for public health decisions.

  2002influential citation
• Prospects for chemoprevention of cancer

  2002cites this paper